Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Miravitlles

Showing results (331-340 of 564) with videos related to

Pageof 57
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 17, 2004
Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease?Carlos Jiménez-Ruiz, Marc Miravitlles, Víctor Sobradillo, et al.
Therapeutic Advances in Respiratory Disease|September 17, 2011
Compliance with guidelines in the treatment of asthma exacerbations in primary careXavier Flor-Escriche, Montserrat Rodríguez-Mas, Maria Espiau, et al.
Respiratory Research|January 22, 2021
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness studyHelgo Magnussen, Sarah Lucas, Therese Lapperre, et al.
Advances in Therapy|March 15, 2021
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims DatabaseJennifer K Quint, Jukka Montonen, Daina B Esposito, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 24, 2022
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviewsMarc Miravitlles, Mike Herepath, Asim Priyendu, et al.
Respiratory Research|September 12, 2024
Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysisBarbara Bonnesen, Josefin Eklöf, Tor Biering-Sørensen, et al.
Respiratory Medicine|March 15, 2012
Perspectives for improving the evaluation and access of therapies for rare lung diseases in EuropeMaurizio Luisetti, Ian M Balfour-Lynn, Simon R Johnson, et al.
Archivos De Bronconeumologia|September 10, 2025
Criteria for Advanced COPD in Patients Hospitalized Due to COPD Exacerbation: Prevalence and Predictive CapacityAlberto Fernández-Villar, Alberto Fernández-García, Cristina Represas-Represas, et al.
Respiratory Research|July 11, 2020
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trialKlaus F Rabe, David M G Halpin, MeiLan K Han, et al.
American Journal of Respiratory and Critical Care Medicine|April 20, 2018
Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease ExacerbationsAlex J Mackay, Konstantinos Kostikas, Lindsey Murray, et al.
Pageof 57

Showing results (331-340 of 564) with videos related to

Sort By:
Pageof 57
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 17, 2004
Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease?Carlos Jiménez-Ruiz, Marc Miravitlles, Víctor Sobradillo, et al.
Therapeutic Advances in Respiratory Disease|September 17, 2011
Compliance with guidelines in the treatment of asthma exacerbations in primary careXavier Flor-Escriche, Montserrat Rodríguez-Mas, Maria Espiau, et al.
Respiratory Research|January 22, 2021
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness studyHelgo Magnussen, Sarah Lucas, Therese Lapperre, et al.
Advances in Therapy|March 15, 2021
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims DatabaseJennifer K Quint, Jukka Montonen, Daina B Esposito, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 24, 2022
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviewsMarc Miravitlles, Mike Herepath, Asim Priyendu, et al.
Respiratory Research|September 12, 2024
Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysisBarbara Bonnesen, Josefin Eklöf, Tor Biering-Sørensen, et al.
Respiratory Medicine|March 15, 2012
Perspectives for improving the evaluation and access of therapies for rare lung diseases in EuropeMaurizio Luisetti, Ian M Balfour-Lynn, Simon R Johnson, et al.
Archivos De Bronconeumologia|September 10, 2025
Criteria for Advanced COPD in Patients Hospitalized Due to COPD Exacerbation: Prevalence and Predictive CapacityAlberto Fernández-Villar, Alberto Fernández-García, Cristina Represas-Represas, et al.
Respiratory Research|July 11, 2020
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trialKlaus F Rabe, David M G Halpin, MeiLan K Han, et al.
American Journal of Respiratory and Critical Care Medicine|April 20, 2018
Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease ExacerbationsAlex J Mackay, Konstantinos Kostikas, Lindsey Murray, et al.
Pageof 57